Fengxiu Ouyang1, Matthew P Longnecker1, Scott A Venners1, Sara Johnson1, Susan Korrick1, Jun Zhang1, Xiping Xu1, Parul Christian1, Mei-Cheng Wang1, Xiaobin Wang1. 1. From the Ministry of Education-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (FO); the Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, Department of Health and Human Services, Research Triangle Park, NC (MPL); the Simon Fraser University, Faculty of Health Sciences, Burnaby, Canada (SAV); the Division of General Pediatrics & Adolescent Medicine, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD (SJ and XW); the Department of Environmental Health, Harvard School of Public Health, Boston, MA (SK); the Shanghai Jiaotong University School of Public Health, Shanghai, China (JZ); the National Clinical Research Center of Kidney Disease; State Key Laboratory of Organ Failure Research; Nanfang Hospital, Southern Medical University, Guangzhou, China (XX); and the Departments of International Health (PC) and Biostatistics (M-CW) and Center on Early Life Origins of Disease, Department of Population, Family and Reproductive Health (XW), Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.
Abstract
BACKGROUND: Although preconception 1,1,1-trichloro-2,2,bis(p-chlorophenyl)ethane (DDT) exposure and B-vitamin deficiencies have each been shown to negatively affect human reproductive outcomes, little is known about their joint effect. OBJECTIVE: We sought to examine whether B-vitamin sufficiency protects against adverse effects of DDT on clinical pregnancy (CP) and subclinical early pregnancy loss (EPL). DESIGN: We measured preconception concentrations of plasma B vitamins (vitamin B-6, vitamin B-12, and folate) and serum total DDT [sum of p,p' and o,p' isomers of DDT and 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene] in 291 nulligravid women from Anhui, China, who were studied in 1996-1998. The women were followed prospectively from the time they stopped contraception until CP (gestational age ≥42 d) or 12 mo (whichever occurred first). EPL was identified by using daily urinary human chorionic gonadotropin. The women were categorized according to B-vitamin status (deficiency compared with sufficiency) and DDT concentration (high compared with low). RESULTS: Of 291 study women, a total of 385 conceptions (31% of which ended in EPL) and 265 CPs occurred. Compared with women with adequate B-vitamins and low DDT, incidence rates of CP were reduced in women with B-vitamin deficiency and a high DDT concentration (P < 0.05 for all). Most notably, in women with sufficient vitamin B-12, DDT was not associated with the incidence of CP; in contrast, in women with vitamin B-12 deficiency, high DDT was associated with a lower incidence of CP (HR: 0.44; 95% CI: 0.23, 0.84); and the test for interaction was significant (P < 0.05). The odds of EPL decreased by 45% (95% CI: 21%, 62%) for each interquartile distance increase in folate in women with high DDT concentrations, and the test for interaction was significant (P = 0.006). CONCLUSIONS: Our results provide suggestive evidence that vitamin B-12 and folate sufficiency may help protect against adverse reproductive effects of DDT exposure. Additional studies are needed to confirm our findings.
BACKGROUND: Although preconception 1,1,1-trichloro-2,2,bis(p-chlorophenyl)ethane (DDT) exposure and B-vitamin deficiencies have each been shown to negatively affect human reproductive outcomes, little is known about their joint effect. OBJECTIVE: We sought to examine whether B-vitamin sufficiency protects against adverse effects of DDT on clinical pregnancy (CP) and subclinical early pregnancy loss (EPL). DESIGN: We measured preconception concentrations of plasma B vitamins (vitamin B-6, vitamin B-12, and folate) and serum total DDT [sum of p,p' and o,p' isomers of DDT and 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene] in 291 nulligravid women from Anhui, China, who were studied in 1996-1998. The women were followed prospectively from the time they stopped contraception until CP (gestational age ≥42 d) or 12 mo (whichever occurred first). EPL was identified by using daily urinary human chorionic gonadotropin. The women were categorized according to B-vitamin status (deficiency compared with sufficiency) and DDT concentration (high compared with low). RESULTS: Of 291 study women, a total of 385 conceptions (31% of which ended in EPL) and 265 CPs occurred. Compared with women with adequate B-vitamins and low DDT, incidence rates of CP were reduced in women with B-vitamin deficiency and a high DDT concentration (P < 0.05 for all). Most notably, in women with sufficient vitamin B-12, DDT was not associated with the incidence of CP; in contrast, in women with vitamin B-12deficiency, high DDT was associated with a lower incidence of CP (HR: 0.44; 95% CI: 0.23, 0.84); and the test for interaction was significant (P < 0.05). The odds of EPL decreased by 45% (95% CI: 21%, 62%) for each interquartile distance increase in folate in women with high DDT concentrations, and the test for interaction was significant (P = 0.006). CONCLUSIONS: Our results provide suggestive evidence that vitamin B-12 and folate sufficiency may help protect against adverse reproductive effects of DDT exposure. Additional studies are needed to confirm our findings.
Authors: R J Berry; Z Li; J D Erickson; S Li; C A Moore; H Wang; J Mulinare; P Zhao; L Y Wong; J Gindler; S X Hong; A Correa Journal: N Engl J Med Date: 1999-11-11 Impact factor: 91.245
Authors: Germaine M Buck Louis; Rajeshwari Sundaram; Enrique F Schisterman; Anne M Sweeney; Courtney D Lynch; Robert E Gore-Langton; José Maisog; Sungduk Kim; Zhen Chen; Dana B Barr Journal: Environ Health Perspect Date: 2012-11-14 Impact factor: 9.031
Authors: Félix Salazar-García; Esperanza Gallardo-Díaz; Prudencia Cerón-Mireles; Dana Loomis; Victor H Borja-Aburto Journal: Environ Health Perspect Date: 2004-04 Impact factor: 9.031
Authors: Wanyu Huang; Tak Igusa; Guoying Wang; Jessie P Buckley; Xiumei Hong; Eric Bind; Andrew Steffens; Jhindan Mukherjee; Douglas Haltmeier; Yuelong Ji; Richard Xu; Wenpin Hou; Zhihua Tina Fan; Xiaobin Wang Journal: Int J Obes (Lond) Date: 2022-05-19 Impact factor: 5.551
Authors: Amanda J Goodrich; Heather E Volk; Daniel J Tancredi; Rob McConnell; Fred W Lurmann; Robin L Hansen; Rebecca J Schmidt Journal: Autism Res Date: 2017-11-09 Impact factor: 4.633
Authors: Rebecca J Schmidt; Vladimir Kogan; Janie F Shelton; Lora Delwiche; Robin L Hansen; Sally Ozonoff; Claudia C Ma; Erin C McCanlies; Deborah H Bennett; Irva Hertz-Picciotto; Daniel J Tancredi; Heather E Volk Journal: Environ Health Perspect Date: 2017-09-08 Impact factor: 9.031
Authors: Guoying Wang; Jessica DiBari; Eric Bind; Andrew M Steffens; Jhindan Mukherjee; Tami R Bartell; David C Bellinger; Xiumei Hong; Yuelong Ji; Mei-Cheng Wang; Marsha Wills-Karp; Tina L Cheng; Xiaobin Wang Journal: BMC Med Date: 2019-11-28 Impact factor: 11.150